Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Final Trades: Eli Lilly, Quest Diagnostics, Northrop Grumman & more
02:27pm, Friday, 30'th Sep 2022
The "Halftime Report" traders give their top picks to watch for the second half.
LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
11:17am, Thursday, 29'th Sep 2022
The success of Biogen (BIIB)-Eisai's AD candidate in a big phase III study makes investors optimistic about the prospects of other AD candidates as well.
7 Growth Stocks to Buy to Tap Into a Hidden Bull Market
08:43pm, Wednesday, 28'th Sep 2022
Even though the stock market has performed miserably lately, and throughout most of 2022, macroeconomic data shows there is reason to be hopeful equities can rebound meaningfully sooner rather than la
Biotech Stocks LLY, ESALY Gain on Biogen's Positive Trial Results
01:39pm, Wednesday, 28'th Sep 2022
Amid a notable positive session for the major equity indices, Biogen (NASDAQ: BIIB ) really got the party started with a massive 37% boost in the early afternoon session on Wednesday. Biogen disclosed
AZN vs. LLY: Which Stock Is the Better Value Option?
12:47pm, Wednesday, 28'th Sep 2022
AZN vs. LLY: Which Stock Is the Better Value Option?
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
12:01pm, Wednesday, 28'th Sep 2022
Positive results for Biogen's Alzheimer's disease candidate are boosting all three stocks.
Analysis: Alzheimer's drug breakthrough big boost for Roche, Eli Lilly
10:03am, Wednesday, 28'th Sep 2022
The results of a key Alzheimer's drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of the fatal brain disease, giving a big boos
Here Are 25 Billion Reasons to Invest in Eli Lilly
09:53am, Wednesday, 28'th Sep 2022
The drugmaker is expertly planning for the future.
A Biotech Breakthrough Means Big Gains for These 2 Stocks
09:16am, Wednesday, 28'th Sep 2022
The news could be good for patients suffering from a debilitating disease.
This ‘fallen angel will grow 30% for the next five years': Crawford
08:31pm, Tuesday, 27'th Sep 2022
Nvidia Corporation (NASDAQ: NVDA) is a “fallen angel” that continues to be a great pick for the long-term investors, according to Ankur Crawford – Portfolio Manager at Alger.
This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?
06:15am, Tuesday, 27'th Sep 2022
Shares of this well-established drugmaker could soar on the back of a new diabetes drug.
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
08:00am, Saturday, 24'th Sep 2022
S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market. The post S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market appeared fi
Eli Lilly stock upgraded to Buy on forecast for new diabetes drug
10:06am, Friday, 23'rd Sep 2022
This segment originally aired on September 22, 2022. UBS analysts upgraded Eli Lilly stock to Buy, stating that the pharma company's Type 2 diabetes medication could become a best-selling drug.
Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength?
04:31am, Friday, 23'rd Sep 2022
Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the n
7 Stocks to Buy That Can Soar in Good Times or in Bad
04:55pm, Thursday, 22'nd Sep 2022
Many commentators, analysts, and economists are convinced that the U.S. will enter a recession next year. Given the strength of the labor market and of corporate balance sheets, along with the onshori
